Skip to main content

Table 4 Discrete choice experiment results

From: Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS)

Factor

ORa(95% CI)

RIa

WTAa(95%CI) ($AUD)

Pain Efficacy b (decreasing)

1.00 (0.97-1.04)

N/Aa

0.08 (0.04-0.11)

Mode of action c (Slow OA a )

1.17 (1.09-1.25)*

5

13.83 (13.73-13.93)

Dose frequency b (once/day)

1.02 (0.96-1.08)

 

0.58 (0.42-0.75)

Treatment Schedule c (daily)

0.90 (0.89-0.9)*

4

4.11 (3.92-4.29)

Cost b (increasing)

0.97 (0.97-0.98)*

2

N/Aa

Prescription b (Yes)

1.03 (0.97-1.09)

N/A a

1.00 (0.83-1.16)

Side effects

Drowsy/constipatedc

1.55 (1.48-1.62)*

6

18.06 (17.90-18.23)

Heartburn/reflux, stomach ulcersc

0.76 (0.75-0.78)*

3

10.67 (10.55-10.78)

High blood pressure, heart/kidney/liver problemsc

0.09 (0.08-0.11)*

1

90.50 (89.38-91.62)

Constant b (α)

N/Aa

N/Aa

 

Model Fit Statistics

Log Likelihood

−1271

McFaddens ρ2 adjusted

0.37

AICa

0.869

  1. *P < 0.001.
  2. a: OR Odds Ratio, RI Relative Importance, WTA Willingness to Accept, OA Osteoarthritis, N/A not applicable, AIC Akaike’s Information Criterion.
  3. b: Non-random parameter c: Random parameter.